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Background: Ghrelin and leptin are hormones implicated in energy balance coordination and body weight regulation. There are conflicting
data regarding the levels and role of leptin while ghrelin has not been studied in CF. The aim of this study was to investigate fasting serum
ghrelin and leptin levels in CF adolescents as compared to healthy controls and analyze their association with body fat.
Methods: Fourteen CF adolescents having pancreatic insufficiency and twenty healthy adolescents were enrolled in the study. Diabetic
patients were excluded. In all participants' height, weight, body mass index (BMI) and body fat % (BF %) were estimated. Ghrelin and leptin
levels were determined after an overnight fast.
Results: Weight, BMI and BF% were significantly lower in CF adolescents than those of controls. Fasting leptin levels in CF were
significantly higher in CF patients ( p=0.030), compared to controls and significantly lower in CF males as compared to CF females
( p=0.01). Fasting ghrelin levels were significantly lower in CF males as compared to male controls ( pb0.001) and comparable in females.
Conclusions: As the overall clinical outcome of CF patients is related to the nutritional status and body weight, the role of ghrelin and leptin
in these patients needs to be elucidated.
© 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Ghrelin; Leptin; Cystic fibrosis; Body fat1. Introduction
Cystic Fibrosis (CF) is a disease characterized by chronic
energy deficiency [1]. CF patients' survival is positively
associated with body weight and body fat [2]. Although the
survival and the overall clinical outcome of patients with CF
have improved over the last decades, [3], there is still signi-☆ This work was presented as oral presentation at the 29th European
Cystic Fibrosis Conference, Copenhagen, Denmark 15–18 June 2006,
Abstract 304.
⁎ Corresponding author. 4th Department of Pediatrics, Medical School,
Aristotle University of Thessaloniki, Papageorgiou General Hospital, Ring
Road Nea Efkarpia, 56403 Thessaloniki, Greece. Tel.: +30 2310 991537;
fax: +30 2310 991535.
E-mail address: charis@med.auth.gr (C. Stylianou).
1569-1993/$ - see front matter © 2006 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2006.10.011ficant difference in body height and weight of these patients
as compared to healthy individuals [4].
Ghrelin and leptin are hormones, which are implicated in
energy balance coordination and body weight regulation.
Leptin was first discovered as a protein encoded by the
obesity gene [5]. It is secreted by fat tissue and has been
found to inhibit food intake and increase energy expenditure
[6]. Leptin levels may reflect the amount of body fat. They
are high in obese and low in lean individuals [7]. There are
conflicting data regarding the levels and role of leptin in CF.
In adult CF patients, leptin levels were found similar to those
of controls [8]. Elevated leptin levels were recently reported
in CF children and adolescents [9].
Ghrelin is a newly-discovered gastrointestinal hormone,
which was discovered initially as an endogenous ligand for the
growth hormone secretagogue receptor (GHS-R) [10,11].ed by Elsevier B.V. All rights reserved.
Table 1
CFTR mutations in the CF patient group
n PATIENTS GENDER GENOTYPE
1 T.E F ΔF508/-
2 S.E F ΔF508/621+G→ T
3 G.D F ΔF508/W1282X
4 K.A F Δ/G542Y
5 N.V F E822X/-
6 D.E F ΔF508/ΔF508
7 M.A F ΔF508/-
8 K.C M ΔF508/-
9 S.D M ΔF508/-
10 P.N M ΔF508/ΔF508
11 D.G M ΔF508/R553X
12 K.P M -/-
13 M.P M ΔF508/-
14 A.C M ΔF508/3849+10KBNT
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to produce positive energy balance by promoting food intake
and decreasing energy expenditure [12]. Ghrelin levels are
decreased in human obesity [13]. Individuals in catabolic state
such as in anorexia nervosa are reported to have high serum
ghrelin [14]. So far, ghrelin has not been studied inCF patients,
who are known to be in a state of chronic energy deficit.
The aim of the present study was to investigate fasting
serum ghrelin and leptin levels in CF adolescents as com-
pared to healthy controls and analyze the association of these
hormones with the percentage of body fat.
2. Methods
2.1. Patients
Fourteen CF adolescents (7 males and 7 females, mean
age of 19.06±5.08, range 12.80 to 25.02 years) were en-
rolled in the study. Diagnosis of CF was based on high sweat
chloride concentrations on two occasions and confirmed by
genetic typing (Table 1). All CF patients were exocrine
pancreatic insufficient and received pancreatic enzyme
replacement therapy. Patients with CF related diabetes
mellitus (CF-DM) were excluded. None of the CF patients
had gastrostomy tube feeds or parenteral nutrition. They
were stable and had no pulmonary exacerbation as verifiedTable 2
Anthropometric characteristics and hormonal values in CF adolescents and health
CF (N=14) Contro
M (n=7) F (n=7) M (n=
Height (cm) 164.71±15.45 156.7±7.84 173.
Weight (kg) 48.21±9.78 46.57±8.88 69.4
BMI (kg/m2) 17.61±1.41 18.90±2.81 22.
BF (%) 10.41±3.95 17.11±3.54 18.7
Leptin levels (ng/ml) 11.27±1.54 21.57±7.68 8.7
Ghrelin levels (pmol/l) 687.93±272.39 ⁎ 1086.94±354.20 1353.4
CF: cystic fibrosis patients, M: male, F: female, BMI: body-mass index, BF: bo
NS: non-significant (N0.05).with physical examination, leukocyte count and negative C-
reactive protein (CRP).Twenty healthy adolescents matched
for age and sex (10 females and 10 males, mean age 19.05±
5.69 years) served as the control group.
All the participants were screened by medical history and
physical examination. Body weight and height were mea-
sured in duplicate using a SEGAweighing-scale and stadio-
meter (SEGA 711 and SEGA 220). Body mass index (BMI)
was calculated (weight in kilograms divided by the square of
height in meters). Bioelectrical Impedance Analysis (BIA)
(MALTRON analyzer BF-906) was applied to estimate body
fat % (BF %) according to the manufacturer's and NIH in-
structions [15].
After an overnight fast, morning blood samples were drawn
from CF patients and healthy controls. Blood samples were
centrifuged (10 min at 1500 g) and the aliquots were stored at
−20 °C without additives until assayed according to the
instructions published by Groeschl et al. regarding ghrelin
[16].
2.2. Leptin assessment
Serum leptin levels were measured applying a solid-phase,
two-site immunometric assay (Immulite 2000; DPC, USA),
which had a CVof 4.1–7.3% and a sensitivity of 2 μIU/ml.
2.3. Ghrelin assessment
Serum ghrelin levels were measured by a commercial
radioimmunoassay (Phoenix Pharmaceuticals, Inc. Belmont,
CA, USA). This assay uses a 125I-labeled ghrelin tracer and a
rabbit polyclonal antibody against full-length, octanoylated
human ghrelin that recognizes the acylated and des-acyl
forms. The antiserum does not cross-react with any relevant
peptide according to the information provided by the manu-
facturer. The lower and upper detection limits were 80 and
2500 pg/ml. The intra- and the interassay coefficients of
variation (CV) were 5.30% and 13.61%, respectively.
2.4. Ethical considerations
This study was approved by the Scientific Ethics Com-
mittee of the Medical School of Aristotle University ofy controls (mean±Standard Deviation)
ls (N=20) P (2-way ANOVA)
10) F (n=10) CF Gender CF⁎Gender
4±14.48 163.7±9.63 0.077 0.047 NS
5±19.49 58.2±4.33 0.001 NS NS
6±3.26 21.81±2.29 0.001 NS NS
1±3.68 21.51±4.07 0.000 0.000 NS
8±5.59 14.89±5.71 0.030 0.000 NS
6±313.28 1138.43±234.18 0.001 NS 0.005
dy fat, ⁎:Pb0.05 compared to male controls (post-hoc one-way ANOVA),
Fig. 2. Ghrelin levels in CF adolescents and healthy controls according to
gender.
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informedwritten consent was obtained from the adult patients
or parents of the adolescents who underwent clinical and
biochemical investigation.
2.5. Statistical analysis
No previous data on ghrelin and leptin levels in patients
with CF was available and for technical reasons, the design of
the present study was feasibility— rather than power-based.
In order to avoid type I error (false statistical significance),
comparisons of means were performed with multivariate
General Linear Model (GLM)-based two-way Analysis Of
Variance (ANOVA). To be conservative with the application
of ANOVA, one-way ANOVAwith post-hoc analysis for pair
wise comparisons after Bonferroni adjustment was used
when the interaction term had a Pb0.05.
3. Results
Weight, BMI and BF% were significantly lower in CF
adolescents as compared to controls ( p=0.001, p=0.001,
pb0.001). A borderline difference in height ( p=0.077) was
observed between patients and controls (Table 2). No sig-
nificant difference was observed in weight, height or BMI
between males and females, but BF % was significantly
higher in females ( pb0.001). No significant interaction
between CF and sex was observed with respect to height,
weight, BMI and BF%. Fasting leptin levels were signifi-
cantly higher in CF individuals ( p=0.030), as compared to
controls. Leptin levels were significantly lower in CF males
than CF females ( pb0.001), with no significant interaction
between the two factors (Fig. 1). CF had negative effect on
fasting ghrelin levels ( p=0.001). Significant interaction wasFig. 1. Leptin levels in CF adolescents and healthy controls according to
gender.observed ( p=0.005). Indeed, in post-hoc analysis, fasting
ghrelin levels were significantly lower in CF males, com-
pared to male controls ( pb0.001), whereas no difference was
observed in females, both CF and controls (Fig. 2). As ex-
pected, leptin levels in CF and controls had positive corre-
lation with BF% (r=0.75). Ghrelin levels had no correlation
with BF%. Furthermore, no linear correlation was observed
between leptin and ghrelin values.
4. Discussion
Leptin as well as ghrelin are hormones, which play a
central role in energy balance coordination and the regu-
lation of appetite and food intake. Leptin inhibits food intake
and increases energy expenditure where ghrelin produces a
positive energy balance by promoting food intake and de-
creasing energy expenditure.
As expected, in this study population, the weight, BMI
and BF% were significantly lower in CF adolescents as
compared to controls. Despite their lower BF%, CF patients
had higher leptin levels than controls. CF males, whose fat
levels were lower, had lower leptin levels than CF females.
The high leptin levels may be attributed to a stimulatory
effect of cytokines, which mediate the inflammatory res-
ponse to chronic infection in CF and may modify the relation
between body fat and leptin. Pro-inflammatory cytokines
(IL-1, IL-6 and TNF a) are known to regulate adipose tissue
metabolism [17]. In the literature there are conflicting data
regarding the levels of leptin in CF. In a study conducted by
Arumugan et al., leptin levels of adult CF patients were
found similar to those of controls [8]. However, Ahmed et al
reported elevated leptin levels in children and adolescents
with CF [9]. In a recent study conducted in CF adults, levels
of adiponectin, another hormone secreted by adipocytes in
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was attributed to the increased central accumulation of fat,
which was measured by a dual X-ray absorptiometry [18].
These findings could also provide an explanation for the
elevated leptin levels in CF individuals. Data on fasting
serum ghrelin levels in CF have not been published, so far.
Fasting serum ghrelin levels in CF patients, measured for the
first time in this study, were significantly lower than those of
controls. The significance of this finding remains to be
elucidated.
Concerning the relationship of leptin and ghrelin with
body composition, leptin levels had positive correlation with
BF %, as expected [7], while ghrelin levels had no corre-
lation. Although ghrelin and leptin are functional antagonists,
there was no linear correlation between ghrelin and leptin
values. The lower ghrelin levels observed in CF individuals
may represent a reaction to the higher leptin levels, as ghrelin
and leptin may be operating as ametabolic switch. The results
of our study, which documented high leptin and low ghrelin
levels in CF, could provide an explanation and could also be
an additional factor of the decreased appetite and the poor
weight gain observed in CF patients, at least in males.
In conclusion, as the overall clinical outcome of CF pa-
tients is related to the nutritional status and body weight, it is
of enormous importance to elucidate the role of ghrelin, one
of the main regulators of appetite, which is decreased in CF
patients.
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